Literature DB >> 2295933

Preparation of [99mTc]HM-PAO.

C Piera, A Pavía, P Bassa, J García.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2295933

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

Review 1.  Radiopharmaceuticals: state of the art.

Authors:  A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1990

2.  Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.

Authors:  K Ozker; B D Collier; R S Hellman; A T Isitman; F Uzum; F G Steffel
Journal:  Eur J Nucl Med       Date:  1995-02

3.  Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model.

Authors:  Hamed Ghazavi; Seyed Javad Hoseini; Alireza Ebrahimzadeh-Bideskan; Baratali Mashkani; Soghra Mehri; Ahmad Ghorbani; Kayvan Sadri; Elahe Mahdipour; Faezeh Ghasemi; Fatemeh Forouzanfar; Azar Hoseini; Ali Reza Pasdar; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

4.  Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.

Authors:  K O Mang'era; H P Vanbilloen; C W Schiepers; A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1995-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.